These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7094664)

  • 1. Parenteral rifampicin in tuberculous and severe non-mycobacterial infections. Clinical data on 237 patients.
    Kissling M; Bergamini N; Xilinas M
    Chemotherapy; 1982; 28(3):229-39. PubMed ID: 7094664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rimactan parenteral formulation in clinical use.
    Kissling M; Xilinas M
    J Int Med Res; 1981; 9(6):459-9. PubMed ID: 7319132
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review).
    Kissling M; Bergamini N
    Chemotherapy; 1981; 27(5):368-402. PubMed ID: 7021080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.
    Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R
    Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
    Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
    Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
    Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
    Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin-containing antibiotic combinations in the treatment of difficult infections.
    Grüneberg RN; Emmerson AM; Ridgway GL
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():49-55. PubMed ID: 6469890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous use of rifampicin.
    Nilsson BS; Boman G
    Eur J Respir Dis; 1981 Jun; 62(3):212-4. PubMed ID: 7308336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of amoxicillin-clavulanic acid (Xiclav) efficacy and the possibility of early switch from parenteral to oral therapy in the treatment of infections].
    Ahmetagić S; Jusufović E; Cengić D; Koluder N; Bajramović N; Calkić L; Hadzić E; Salaka U; Sijercić M
    Med Arh; 2003; 57(5-6):263-6. PubMed ID: 15022575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
    Kurashige T; Wakiguchi H; Kitamura I; Ozaki H; Nishibayashi Y; Hamawaki M
    Jpn J Antibiot; 1982 Nov; 35(11):2579-88. PubMed ID: 6302339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.
    Te Brake L; Dian S; Ganiem AR; Ruesen C; Burger D; Donders R; Ruslami R; van Crevel R; Aarnoutse R
    Int J Antimicrob Agents; 2015 May; 45(5):496-503. PubMed ID: 25703312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of cefminox in the treatment of various infections of infants and children].
    Kurashige T; Tone Y; Kuramitsu M; Morita H; Wakiguchi H; Ogura H; Kitamura I; Hamawaki M; Kubonishi S; Ozaki H
    Jpn J Antibiot; 1985 Mar; 38(3):773-83. PubMed ID: 3897608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin.
    Mathivha KT; Velaphi S
    Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical evaluation of a new cephamycin antibiotic, cefotetan, in pediatrics].
    Nakazawa S; Sato H; Niino K; Suzuki H; Nakazawa S; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1983 Jun; 36(6):1219-32. PubMed ID: 6581328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of an injectable form of rifampicin in severe banal pyogenic infections in a resuscitation setting].
    Wattel F; Martin G; Durocher A; Courcol R; Fourrier F; Fruchart A; Dubois D; Mathieu D
    LARC Med; 1982 Oct; 2(9):812-6, 819. PubMed ID: 7162285
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.